Leonard M. Tannenbaum filed Amendment No. 6 to Schedule 13D with the SEC on November 9, 2026, disclosing a beneficial ownership position of 6,269,981 shares, or 28.5%, of Sunrise Realty Trust, Inc. common stock following open market purchases and the November 5, 2026 closing …
Bradford T. Whitmore and affiliated entities filed Amendment No. 22 to a Schedule 13D with the SEC on November 9, 2026, disclosing beneficial ownership positions in Solesence, Inc. common stock as of a triggering event dated November 5, 2026.
Farallon Capital Management, L.L.C. and thirteen associated individuals filed a Schedule 13G with the SEC on November 9, 2026, disclosing a beneficial ownership position in Exelixis, Inc. common stock.
Farallon Capital Management, L.L.C. filed Amendment No. 9 to its Schedule 13D with the SEC on November 9, 2026, disclosing a beneficial ownership position of 12,017,906 shares of Exelixis, Inc. common stock as of November 6, 2026.
EON Resources Inc. filed a preliminary proxy statement on November 9, 2026, soliciting stockholder votes on five proposals at the company's 2026 annual meeting scheduled for December 17, 2026 at 2:30 P.M. Eastern Time.
Jaws Mustang Acquisition Corporation filed a preliminary proxy statement on November 9, 2026, asking shareholders to vote on extending the company's business combination deadline from December 4, 2026 to December 4, 2028.
Timur R. Turlov, CEO and Chairman of Freedom Holding Corp., filed Amendment No. 5 to his Schedule 13D on November 9, 2026, disclosing a heads of terms agreement dated November 5, 2026, under which he and his entity Turlov Private Holding Ltd. would transfer …
European Lithium Limited filed Amendment No. 8 to Schedule 13D with the SEC on November 9, 2026, disclosing that Critical Metals Corp. completed its acquisition of European Lithium on November 5, 2026, making European Lithium a wholly owned subsidiary of Critical Metals Corp. (NASDAQ:CRML).
Korsana Biosciences, Inc. filed a Form S-8 registration statement with the SEC on November 9, 2026, registering a combined 13,726,188 shares of common stock issuable under three equity compensation plans following its September 2026 merger with the former private Korsana Biosciences entity.
NorthStar Earth & Space Enterprises, Inc. filed Post-Effective Amendment No. 3 to Registration Statement No. 333-297008 on Form F-4 with the SEC on November 9, 2026, as successor to Viking Acquisition Corp. I following the closing of their Business Combination on October 1, 2026.